PT Inquest is an online journal club. Hosted by Jason Tuori, Megan Graham, and Chris Juneau, the show looks at an article every week and discusses how it applies to current physical therapy practice.
…
continue reading
Content provided by ReachMD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ReachMD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Selecting High-Risk Mantle Cell Lymphoma Patients for CAR T-Cell Therapy
MP3•Episode home
Manage episode 444603630 series 1934671
Content provided by ReachMD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ReachMD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Tara Graff, DO, MS
When it comes to managing patients with high-risk mantle cell lymphoma, several factors impact their candidacy for CAR T-cell therapy, including time to relapse, TP53 mutation status, age, and even social considerations. Joining Dr. Charles Turck to discuss how we can use these factors to identify patients with high-risk mantle cell lymphoma who would most likely benefit from CAR T-cell therapy is medical oncologist Dr. Tara Graff.
…
continue reading
Guest: Tara Graff, DO, MS
When it comes to managing patients with high-risk mantle cell lymphoma, several factors impact their candidacy for CAR T-cell therapy, including time to relapse, TP53 mutation status, age, and even social considerations. Joining Dr. Charles Turck to discuss how we can use these factors to identify patients with high-risk mantle cell lymphoma who would most likely benefit from CAR T-cell therapy is medical oncologist Dr. Tara Graff.
155 episodes
MP3•Episode home
Manage episode 444603630 series 1934671
Content provided by ReachMD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ReachMD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Tara Graff, DO, MS
When it comes to managing patients with high-risk mantle cell lymphoma, several factors impact their candidacy for CAR T-cell therapy, including time to relapse, TP53 mutation status, age, and even social considerations. Joining Dr. Charles Turck to discuss how we can use these factors to identify patients with high-risk mantle cell lymphoma who would most likely benefit from CAR T-cell therapy is medical oncologist Dr. Tara Graff.
…
continue reading
Guest: Tara Graff, DO, MS
When it comes to managing patients with high-risk mantle cell lymphoma, several factors impact their candidacy for CAR T-cell therapy, including time to relapse, TP53 mutation status, age, and even social considerations. Joining Dr. Charles Turck to discuss how we can use these factors to identify patients with high-risk mantle cell lymphoma who would most likely benefit from CAR T-cell therapy is medical oncologist Dr. Tara Graff.
155 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.